|
🐜
|
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
20 auth.
C. Louapre,
N. Collongues,
B. Stankoff,
C. Giannesini,
C. Papeix,
C. Bensa,
R. Deschamps,
A. Créange,
A. Wahab,
J. Pelletier,
...
O. Heinzlef,
P. Labauge,
L. Guilloton,
G. Ahle,
M. Goudot,
K. Bigaut,
D. Laplaud,
S. Vukusic,
C. Lubetzki,
J. de Seze
|
8 |
2020 |
8
🐜
|
|
🐜
|
MS and neuromyelitis optica in Martinique (French West Indies)
8 auth.
P. Cabre,
O. Heinzlef,
H. Merle,
G. Buisson,
O. Béra,
R. Bellance,
...
Vernant Jc,
D. Smadja
|
7 |
2001 |
7
🐜
|
|
🐜
|
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.
30 auth.
Mikael Cohen,
E. Maillart,
A. Tourbah,
J. de Seze,
S. Vukusic,
D. Brassat,
O. Anne,
S. Wiertlewski,
W. Camu,
S. Courtois,
A. Ruet,
M. Debouverie,
E. Le Page,
O. Casez,
O. Heinzlef,
...
B. Stankoff,
B. Bourre,
G. Castelnovo,
A. Rico,
E. Berger,
J. Camdessanche,
G. Defer,
P. Clavelou,
Abdullatif Al Khedr,
H. Zéphir,
A. Fromont,
C. Papeix,
B. Brochet,
J. Pelletier,
C. Lebrun
|
7 |
2014 |
7
🐜
|
|
🐜
|
Neuromyelitis optica in France
41 auth.
N. Collongues,
R. Marignier,
H. Zéphir,
C. Papeix,
F. Blanc,
C. Ritleng,
M. Tchikviladzé,
O. Outteryck,
S. Vukusic,
M. Fleury,
B. Fontaine,
D. Brassat,
M. Clanet,
M. Milh,
J. Pelletier,
...
B. Audoin,
A. Ruet,
C. Lebrun-Frénay,
E. Thouvenot,
W. Camu,
M. Debouverie,
A. Créange,
Thibault Moreau,
P. Labauge,
G. Castelnovo,
G. Edan,
E. Page,
G. Defer,
B. Barroso,
O. Heinzlef,
O. Gout,
D. Rodriguez,
S. Wiertlewski,
D. Laplaud,
F. Borgel,
P. Tourniaire,
J. Grimaud,
B. Brochet,
P. Vermersch,
C. Confavreux,
J. Seze
|
7 |
2010 |
7
🐜
|
|
🐜
|
Multiple sclerosis and antecedent infections
7 auth.
R. Marrie,
C. Wolfson,
M. Sturkenboom,
O. Gout,
O. Heinzlef,
E. Roullet,
...
L. Abenhaim
|
6 |
2000 |
6
🐜
|
|
🦁
|
Autoimmune diseases in families of French patients with multiple sclerosis
7 auth.
O. Heinzlef,
Sonia Alamowitch,
V. Sazdovitch,
P. Chillet,
A. Joutel,
Elizabeth Tournier-Lasserve,
...
E. Roullet
|
6 |
2000 |
6
🦁
|
|
🐜
|
Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI.
105 auth.
P. Roca,
A. Attyé,
L. Colas,
A. Tucholka,
P. Rubini,
S. Cackowski,
J. Ding,
J. Budzik,
F. Renard,
S. Doyle,
Emmanuel L Barbier,
I. Bousaid,
R. Casey,
S. Vukusic,
N. Lassau,
...
S. Verclytte,
F. Cotton,
B. Brochet,
J. de Seze,
P. Douek,
F. Guillemin,
D. Laplaud,
C. Lebrun-Frénay,
L. Mansuy,
T. Moreau,
J. Olaiz,
J. Pelletier,
C. Rigaud‐Bully,
B. Stankoff,
R. Marignier,
M. Debouverie,
G. Edan,
J. Ciron,
A. Ruet,
N. Collongues,
C. Lubetzki,
P. Vermersch,
P. Labauge,
G. Defer,
M. Cohen,
A. Fromont,
S. Wiertlewsky,
E. Berger,
P. Clavelou,
B. Audoin,
C. Giannesini,
O. Gout,
E. Thouvenot,
O. Heinzlef,
A. Al-Khedr,
B. Bourre,
O. Casez,
P. Cabre,
A. Montcuquet,
A. Créange,
J. Camdessanche,
J. Faure,
A. Maurousset,
I. Patry,
K. Hankiewicz,
C. Pottier,
N. Maubeuge,
C. Labeyrie,
C. Nifle,
R. Ameli,
R. Anxionnat,
E. Bannier,
C. Barillot,
D. Ben Salem,
M. Boncoeur-Martel,
F. Bonneville,
C. Boutet,
J. Brisset,
F. Cervenanski,
B. Claise,
O. Commowick,
J. Constans,
P. Dardel,
H. Desal,
V. Dousset,
F. Durand-Dubief,
J. Ferré,
E. Gerardin,
T. Glattard,
S. Grand,
T. Grenier,
R. Guillevin,
C. Guttmann,
A. Krainik,
S. Kremer,
S. Lion,
N. Menjot de Champfleur,
L. Mondot,
O. Outteryck,
N. Pyatigorskaya,
J. Pruvo,
S. Rabasté,
J. Ranjeva,
J. Roch,
J. Sadik,
D. Sappey-Marinier,
J. Savatovsky,
J. Tanguy,
A. Tourbah,
T. Tourdias
|
6 |
2020 |
6
🐜
|
|
🐜
|
Cancer and multiple sclerosis in the era of disease-modifying treatments
13 auth.
C. Lebrun,
P. Vermersch,
D. Brassat,
G. Defer,
L. Rumbach,
P. Clavelou,
M. Debouverie,
J. Seze,
Sandrine Wiertlevsky,
O. Heinzlef,
...
A. Tourbah,
A. Fromont,
M. Frénay
|
5 |
2011 |
5
🐜
|
|
🐜
|
Anxiety, emotional processing and depression in people with multiple sclerosis
11 auth.
Marie-Claire Gay,
C. Bungener,
Sarah Thomas,
P. Vrignaud,
Peter W Thomas,
R. Baker,
...
S. Montel,
O. Heinzlef,
C. Papeix,
R. Assouad,
M. Montreuil
|
5 |
2017 |
5
🐜
|
|
🐬
|
Brain infarction following 5-fluorouracil and cisplatin therapy
M. E. Amrani,
O. Heinzlef,
T. Debrouker,
Etienne Roullet,
Marchie‐Germaine Bousser,
P. Amarenco
|
5 |
1998 |
5
🐬
|
